Bone cement safety study withdrawn before starting
NCT ID NCT06699160
First seen Jan 03, 2026 · Last updated May 31, 2026 · Updated 23 times
Summary
This study aimed to confirm the safety and performance of Refobacin Revision-3 Bone Cement in hip or knee revision surgeries. It planned to track implant removal, side effects, pain, function, and quality of life in adults. However, the study was withdrawn before enrolling any participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REVISION ARTHROPLASTY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Diakonessenhuis UMC Utrecht
Utrecht, 3582, Netherlands
Conditions
Explore the condition pages connected to this study.